Greater Civil Society Involvement in Drug Evaluation Will Bring Challenges, Warns EMA Deputy Head

The European Medicines Agency is keen to highlight its landmark policy on proactive publication of clinical data but it’s aware of the challenges involved in this and other transparency initiatives.